Niche Expertise Ionian Technologies specializes in molecular diagnostics for infectious diseases and biothreat agents, representing a focused niche within the biotech space that offers targeted opportunities for partnerships or sales of related diagnostic tools and technologies.

Recent Acquisition Boost Being acquired by Alere Inc. in 2010 suggests a strategic backing that could facilitate access to larger distribution channels, enhanced R&D resources, and potential co-marketing opportunities in infectious disease diagnostics.

Growing Revenue With revenues between 1 million and 10 million dollars, there is significant growth potential to expand product offerings or enter new markets, making them a viable partner for innovative diagnostic solutions.

Small but Agile As a small company with fewer than 10 employees, Ionian Technologies can be highly agile, fast-moving, and receptive to customized solutions, appealing qualities for tailored sales pitches and collaborative projects.

Tech-Driven Approach Utilizing technologies like Apache indicates a focus on robust, scalable tech infrastructure, presenting opportunities for joint development in digital health platforms, data analytics, or cloud-based diagnostic solutions.